main-logo

ICD-10 Code D55.21 | Anemia due to pyruvate kinase deficiency Symptoms, Diagnosis, Billing

Anemia due to pyruvate kinase deficiency is a rare inherited disorder characterized by a deficiency of the enzyme pyruvate kinase, leading to hemolytic anemia. This condition is clinically significant as it can result in severe anemia, requiring accurate diagnosis and management. The ICD-10 Code D55.21 facilitates precise documentation, billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this condition.

What is ICD-10 Code D55.21 for Anemia due to pyruvate kinase deficiency?

ICD-10 Code D55.21 represents Anemia due to pyruvate kinase deficiency, a genetic disorder that impairs red blood cell metabolism, leading to premature destruction of these cells. This code should be used in clinical documentation and billing when diagnosing patients with this specific type of anemia, ensuring appropriate treatment and management strategies are implemented.

ICD-10 Code D55.21 – Clinical Definition and Explanation of Anemia due to pyruvate kinase deficiency

Anemia due to pyruvate kinase deficiency is caused by mutations in the PKLR gene, leading to reduced enzyme activity and subsequent hemolysis of red blood cells. This condition can progress to severe anemia, necessitating medical intervention. Early diagnosis and management are crucial to prevent complications.

Key Clinical Features:

  • Hemolytic anemia with reticulocytosis
  • Jaundice and splenomegaly
  • Fatigue and pallor
  • Increased risk of gallstones

ICD-10 Code D55.21 for Anemia due to pyruvate kinase deficiency – SOAP Notes & Clinical Use

ICD-10 Code D55.21 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to anemia due to pyruvate kinase deficiency. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code D55.21 for Anemia due to pyruvate kinase deficiency Mean in SOAP Notes?

In SOAP notes, ICD-10 Code D55.21 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of anemia due to pyruvate kinase deficiency. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code D55.21 – Anemia due to pyruvate kinase deficiency

Management of anemia due to pyruvate kinase deficiency often requires hospitalization for severe cases. Treatment focuses on supportive care and addressing complications.

Antibiotic Therapy:

  • Not applicable as this condition is not infectious.

Supportive Care:

  • Blood transfusions for severe anemia
  • Folic acid supplementation
  • Splenectomy in recurrent cases

Infection Control:

  • Standard precautions to prevent infections in immunocompromised patients.

How to Document Symptoms of Anemia due to pyruvate kinase deficiency (ICD-10 D55.21) in SOAP Notes

Subjective:

  • Patient reports fatigue and weakness.
  • History of jaundice and dark urine.
  • Family history of hemolytic anemia.
  • Episodes of palpitations during exertion.

Objective:

  • Pallor noted on physical examination.
  • Elevated reticulocyte count.
  • Increased indirect bilirubin levels.
  • Splenomegaly observed on abdominal exam.
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Anemia due to pyruvate kinase deficiency (ICD-10 Code D55.21)

Assessment:

  • Diagnosis: Anemia due to pyruvate kinase deficiency, moderate severity.
  • ICD-10 Code: D55.21.
  • Triggers: Genetic mutation leading to enzyme deficiency.
  • Contributing factors: Family history of similar conditions.

Plan:

  • Initiate blood transfusions as needed.
  • Refer to hematology for further management.
  • Educate patient on dietary modifications and folic acid intake.
  • Schedule follow-up in 1 month to monitor hemoglobin levels.

Treatment & Plan Section for ICD-10 Code D55.21 – Anemia due to pyruvate kinase deficiency

  • Blood transfusions for symptomatic anemia.
  • Folic acid supplementation to support erythropoiesis.
  • Consider splenectomy for patients with severe hemolysis.
  • Regular monitoring of hemoglobin and bilirubin levels.

Using ICD-10 Code D55.21 for Anemia due to pyruvate kinase deficiency in Billing & SOAP Note Compliance

  • Ensure accurate documentation of symptoms and clinical findings.
  • Use D55.21 in appropriate clinical settings for billing.
  • Align treatment plans with clinical guidelines to support justified billing.
  • Document any related complications or comorbidities.

ICD-10 Code D55.21 in Medical Billing and Insurance for Anemia due to pyruvate kinase deficiency

ICD-10 Code D55.21 is critical in medical billing, particularly in hospital and emergency care settings.

Billing Notes:

  • Document all relevant clinical findings to support the use of D55.21.
  • Use this code in inpatient settings for accurate reimbursement.
  • Ensure that the patient's history and treatment plan are clearly outlined in the medical record.
  • Include any complications or related conditions in documentation.

Common CPT Pairings:

CPT CodeDescription
36430Blood transfusion, per unit.
85025Complete blood count (CBC) with automated differential.
88305Pathology examination of blood smear.

Frequently Asked Questions

Common Questions About Using ICD-10 Code D55.21 for Anemia due to pyruvate kinase deficiency

What are the common symptoms of anemia due to pyruvate kinase deficiency?

Common symptoms include fatigue, pallor, jaundice, and splenomegaly. Patients may also experience episodes of shortness of breath and palpitations due to anemia.

How is anemia due to pyruvate kinase deficiency diagnosed?

Diagnosis is typically made through blood tests showing hemolytic anemia, elevated reticulocyte count, and genetic testing to confirm pyruvate kinase deficiency.

What treatment options are available for this condition?

Treatment may include blood transfusions for severe anemia, folic acid supplementation, and splenectomy in recurrent cases to reduce hemolysis.

Is anemia due to pyruvate kinase deficiency hereditary?

Yes, it is an inherited condition caused by mutations in the PKLR gene, and it follows an autosomal recessive inheritance pattern.

diamond-bg
diamond-bg

Get started with your 20 free notes

Sign up for free
main-logo

AI-aided Sudsy Shorthand for ink-free practices

support@soapsuds.io
hipaa-logo

Clinical Notes

SOAP notes

DAP notes

AI medical notes

© Copyright SOAPsuds 2025. All rights reserved